{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:26:04Z","timestamp":1790637964247,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jad.2025.01.059","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T22:40:03Z","timestamp":1738536003000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study"],"prefix":"10.1016","volume":"376","author":[{"given":"Alessandro","family":"Cuomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pardossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Barill\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Carmellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Firenzuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Tinturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fagiolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.01.059_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jad.2004.12.004","article-title":"Agitated \u201cunipolar\u201d depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy","volume":"85","author":"Akiskal","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2025.01.059_bb3000","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.rpsm.2016.05.005","article-title":"Efficacy and safety of ketamine in bipolar depression: A systematic review","volume":"10","author":"Alberich","year":"2017","journal-title":"Rev. Psiquiatr. Salud. Ment."},{"key":"10.1016\/j.jad.2025.01.059_bb0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficiency of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.01.059_bb0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/ijnp\/pyab023","article-title":"Ketamine for bipolar depression: a systematic review","volume":"24","author":"Bahji","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.01.059_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-019-0160-1","article-title":"Bipolar depression: a major unsolved challenge","volume":"8","author":"Baldessarini","year":"2020","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2025.01.059_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2015.06.003","article-title":"Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant","volume":"68","author":"Ballard","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.01.059_bb0030","series-title":"Antidepressants, Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/164_2018_155","article-title":"The use of antidepressants in bipolar depression","author":"Beyer","year":"2018"},{"key":"10.1016\/j.jad.2025.01.059_bb0035","first-page":"38","article-title":"Mixed states: diagnosis, assessment and diagnostic stability","volume":"34","author":"Cervone","year":"2022","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.jad.2025.01.059_bb0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0000000000001227","article-title":"Food and Drug Administration\u2013approved treatments for acute bipolar depression: what we have and what we need","volume":"40","author":"Citrome","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.01.059_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0004867416631828","article-title":"Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation","volume":"51","author":"Cusin","year":"2017","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0050","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/1516-4446-2020-1627","article-title":"Treatment-resistant bipolar depression: concepts and challenges for novel interventions","volume":"44","author":"Diaz","year":"2022","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0060","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/NDT.S273503","article-title":"Treatment-resistant bipolar depression: therapeutic trends, challenges and future directions","volume":"18","author":"Elsayed","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.01.059_bb0065","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0006-3223(02)01670-0","article-title":"Is treatment-resistant depression a unique subtype of depression?","volume":"53","author":"Fagiolini","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1399-5618.2009.00700.x","article-title":"Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study","volume":"11","author":"Fagiolini","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.01.059_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231202723","article-title":"Ketamine for bipolar depression: an updated systematic review","volume":"13","author":"Fancy","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.01.059_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/bdi.13284","article-title":"Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression","volume":"25","author":"Fancy","year":"2023","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.01.059_bb0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/appi.ajp.2008.08030322","article-title":"Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression","volume":"166","author":"Frye","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0447.2008.01257.x","article-title":"Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks","volume":"118","author":"Ghaemi","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.01.059_bb0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40345-018-0133-9","article-title":"Antidepressants in bipolar depression: an enduring controversy","volume":"6","author":"Gitlin","year":"2018","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2025.01.059_bb0100","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2025.01.059_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bdi.12487","article-title":"Ketamine versus midazolam in bipolar depression with suicidal thoughts: a pilot midazolam-controlled randomized clinical trial","volume":"19","author":"Grunebaum","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.01.059_bb0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1192\/bjp.2018.257","article-title":"Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition","volume":"214","author":"Hidalgo-Mazzei","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0125","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.4088\/JCP.14m09049","article-title":"Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine","volume":"75","author":"Ionescu","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0130","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jad.2018.09.037","article-title":"Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial","volume":"243","author":"Ionescu","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.01.059_bb0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ijnp\/pyy094","article-title":"Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments","volume":"22","author":"Kadriu","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.01.059_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1192\/bjp.bp.112.124404","article-title":"Mixed features of depression: why DSM-5 is wrong (and so was DSM-IV)","volume":"203","author":"Koukopoulos","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","article-title":"Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers","volume":"163","author":"Leverich","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0155","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1192\/j.eurpsy.2024.25","article-title":"Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis","volume":"67","author":"Li","year":"2024","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0160","doi-asserted-by":"crossref","first-page":"S574","DOI":"10.1192\/j.eurpsy.2023.1202","article-title":"Mixed states and suicidality in bipolar disorder: results from the Stanley Foundation Bipolar Treatment Network","volume":"66","author":"Macellaro","year":"2023","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/0004867416634208","article-title":"Stimulants for depression: on the up and up?","volume":"50","author":"Malhi","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0170","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.4088\/JCP.13019tx4c","article-title":"Pros and cons of approved therapies for bipolar depression and ongoing unmet needs","volume":"75","author":"McElroy","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852913000746","article-title":"A review of FDA-approved treatment options in bipolar depression","volume":"18","author":"McIntyre","year":"2013","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.01.059_bb0180","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis","volume":"276","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.01.059_bb0185","article-title":"Lumateperone for major depressive episodes in bipolar I or bipolar II disorder","volume":"21","author":"Meyer","year":"2021","journal-title":"Curr. Psychiatr. Ther."},{"key":"10.1016\/j.jad.2025.01.059_bb0190","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2025.01.059_bb0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpsychires.2015.04.014","article-title":"Predictors of switch from depression to mania in bipolar disorder","volume":"66\u201367","author":"Niitsu","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.01.059_bb0200","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0205","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.4088\/JCP.14m09092","article-title":"Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study","volume":"76","author":"Perugi","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0210","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41386-019-0570-x","article-title":"Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression","volume":"45","author":"Phillips","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.01.059_bb0215","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1176\/ajp.128.11.1363","article-title":"Wrist-cutting syndrome: the meaning of a gesture","volume":"128","author":"Rosenthal","year":"1972","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0220","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.2271","article-title":"Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?","volume":"28","author":"Rybakowski","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.jad.2025.01.059_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/appi.ajp.2014.13111517","article-title":"Treatment-Resistant Bipolar Depression: A Randomized Controlled Trial of Electroconvulsive Therapy Versus Algorithm-Based Pharmacological Treatment","volume":"172","author":"Schoeyen","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0230","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.09r05385gre","article-title":"Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis","volume":"72","author":"Sidor","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bdi.12026","article-title":"Evidence - based treatment strategies for treatment- resistant bipolar depression: a systematic review","volume":"15","author":"Sienaert","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.01.059_bb0240","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/14740338.2022.2045272","article-title":"Can ketamine be a safe option for treatment-resistant bipolar depression?","volume":"21","author":"Singh","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2025.01.059_bb0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.ajp.2014.14101215","article-title":"Use of electroconvulsive therapy in bipolar depression","volume":"172","author":"Tohen","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0250","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0447.2009.01514.x","article-title":"Mania associated with antidepressant treatment: comprehensive meta- analytic review","volume":"121","author":"Tondo","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.01.059_bb0255","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1176\/appi.ajp.2014.14070826","article-title":"Antidepressants in bipolar I disorder: never as monotherapy","volume":"171","author":"Vieta","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0260","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.2014.13111501","article-title":"The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer","volume":"171","author":"Viktorin","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0265","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2147\/NDT.S325000","article-title":"Intravenous ketamine infusions in treatment-resistant bipolar depression: an open-label naturalistic observational study","volume":"17","author":"Wilkowska","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.01.059_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0275","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.059_bb0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","article-title":"Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression","volume":"106","author":"Zheng","year":"2018","journal-title":"J. Psychiatr. Res."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272500076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272500076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T16:37:15Z","timestamp":1750351035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503272500076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":57,"alternative-id":["S016503272500076X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.01.059","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.01.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}